Consensus revenue for Q2 2026 is pegged at $10.22 million with an expected EPS loss of $0.07, as the stock trades at $11.91 compared to a $20.60 analyst price target. The primary focus for investors is the company’s progress toward achieving 30 logical qubits in 2026, a critical milestone for commercial quantum computing scalability.
Infleqtion recently secured significant momentum through $100 million in CHIPS Act-related funding and a NASA Quantum Gravity Gradiometer pathfinder contract. However, markets are closely monitoring widening operating losses driven by aggressive R&D and the rollout of new international quantum innovation centers.